NestaCell®

BIOLOGICAL2 trials

Sponsors

Azidus Brasil

Conditions

COVID-19 PneumoniaHuntington Disease

Phase 2

NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia

CompletedNCT04315987

Azidus BrasilCOVID-19 Pneumonia

Start: 2020-06-30End: 2021-02-28Updated: 2022-10-28

Phase 3

Efficacy and Safety of NestaCell® in Huntington's Disease

Not yet recruitingNCT06097780

Azidus BrasilHuntington Disease

Start: 2024-06-08End: 2026-02-09Target: 120Updated: 2023-10-24